Antibiotic treatment of Gram-positive bone and joint infections

被引:197
作者
Darley, ESR [1 ]
MacGowan, AP [1 ]
机构
[1] Southmead Gen Hosp, Bristol Ctr Antimicrobial Res & Evaluat, Bristol BS10 5NB, Avon, England
关键词
staphylococci; streptococci; osteomyelitis; septic arthritis; prosthetic joint infections;
D O I
10.1093/jac/dkh191
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Gram-positive organisms, particularly staphylococci and streptococci, are responsible for the majority of bone and joint infections. Treatment of these infections can be difficult, usually involving a prolonged course of antibiotics, often with surgical intervention. The selection of antibiotics depends on sensitivity profile, patient tolerance and long-term goals, e.g. cure or suppression, but there are few randomized controlled trials in patients comparing efficacy of different antibiotics. Different degrees of bone penetration and clinical outcome for specific antibiotics, e.g. the beta-lactams, clindamycin and quinolones, have been described, although the methodology in these studies is not standardized and findings cannot always be applied directly to patients. The effect of attaining minimum serum bactericidal concentrations in patients has also been studied but this is no longer routinely recommended in clinical practice. Comparative clinical trials are few but have demonstrated efficacy of oral fluoroquinolones in combination with either rifampicin or fusidic acid for selected Gram-positive infections. In the past decade, increasingly resistant organisms, e.g. methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci have been recognized as causes of orthopaedic infection. Individual case reports describe successful treatment using the newer antibiotics, e.g. linezolid and quinupristin/dalfopristin, but results of clinical trials are awaited.
引用
收藏
页码:928 / 935
页数:8
相关论文
共 115 条
[1]  
ALLBERGER F, 1992, INT ORTHOP, V16, P237
[2]   BSAC standardized disc susceptibility testing method [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :43-57
[3]   The diagnosis of large joint sepsis [J].
Atkins, BL ;
Bowler, ICJW .
JOURNAL OF HOSPITAL INFECTION, 1998, 40 (04) :263-274
[4]   COMPARATIVE EFFECT OF PROTEIN-BINDING ON THE KILLING ACTIVITIES OF TEICOPLANIN AND VANCOMYCIN [J].
BAILEY, EM ;
RYBAK, MJ ;
KAATZ, GW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) :1089-1092
[5]   Efficacy and pharmacodynamics of teicoplanin given daily during the first 3 days and then on alternate days for methicillin-resistant Staphylococcus aureus infections [J].
Bantar, C ;
Durlach, R ;
Nicola, F ;
Freuler, C ;
Bonvehí, P ;
Vazquez, R ;
Smayevsky, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (05) :737-740
[6]   Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA) [J].
Bassetti, M ;
Di Biagio, A ;
Cenderello, G ;
Del Bono, V ;
Palermo, A ;
Cruciani, M ;
Bassetti, D .
JOURNAL OF INFECTION, 2001, 43 (02) :148-149
[7]   ORAL AND PARENTERAL AMOXICILLIN CLAVULANIC ACID IN CONJUNCTION WITH SURGERY FOR THE MANAGEMENT OF CHRONIC OSTEOMYELITIS AND SEVERE BONE INFECTION [J].
BASSEY, L .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 52 (06) :922-928
[8]   FURTHER OBSERVATIONS ON VALUE OF ORAL PENICILLINS IN CHRONIC STAPHYLOCOCCAL OSTEOMYELITIS [J].
BELL, SM .
MEDICAL JOURNAL OF AUSTRALIA, 1976, 2 (16) :591-593
[9]   Prosthetic joint infection [J].
Anthony R. Berendt ;
Peter McLardy-Smith .
Current Infectious Disease Reports, 1999, 1 (3) :267-272
[10]   ORAL ANTIMICROBIAL THERAPY FOR ADULTS WITH OSTEOMYELITIS OR SEPTIC ARTHRITIS [J].
BLACK, J ;
HUNT, TL ;
GODLEY, PJ ;
MATTHEW, E .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (05) :968-972